Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 4/20 | 1.00 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 1.00 |
| ▸ | TSHR | P16473 | 3/20 | 0.84 |
| ▸ | TERT | O14746 | 3/20 | 0.56 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.56 |
| ▸ | PPARG | P37231 | 3/20 | 0.56 |
| ▸ | PPARD | Q03181 | 3/20 | 0.56 |
| ▸ | PPARA | Q07869 | 3/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.56 |
| ▸ | MAPT | P10636 | 2/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.56 |
| ▸ | BLM | P54132 | 2/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.56 |
| ▸ | FABP4 | P15090 | 2/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | TOP1 | P11387 | 2/20 | 0.56 |
| ▸ | GMNN | O75496 | 1/20 | 0.56 |
| ▸ | USP2 | O75604 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7889079 | 1.00 | FAAH (1.00) | FAAHTRPV1TSHRTERTPTPN1 | |
| SCHEMBL2734732 | 1.00 | FAAH (1.00) | FAAHTRPV1TSHRTERTPTPN1 | |
| SCHEMBL557466 | 1.00 | FAAH (1.00) | FAAHTRPV1TSHRTERTPTPN1 | |
| SCHEMBL7289314 | 1.00 | FAAH (1.00) | FAAHTRPV1TSHRTERTPTPN1 | |
| SCHEMBL2734273 | 1.00 | FAAH (1.00) | FAAHTRPV1TSHRTERTPTPN1 | |
| SCHEMBL4810143 | 1.00 | FAAH (1.00) | FAAHTRPV1TSHRTERTPTPN1 | |
| SCHEMBL1830971 | 1.00 | FAAH (1.00) | FAAHTRPV1TSHRTERTPTPN1 | |
| SCHEMBL4803153 | 1.00 | FAAH (1.00) | FAAHTRPV1TSHRTERTPTPN1 | |
| SCHEMBL1301131 | 1.00 | FAAH (1.00) | FAAHTRPV1TSHRTERTPTPN1 | |
| SCHEMBL811835 | 1.00 | FAAH (1.00) | FAAHTRPV1TSHRTERTPTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1695 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260137082-A1 | FUNGICIDAL COMPOSITIONS COMPRISING FLUDIOXONIL | SYNGENTA CROP PROTECTION AG (CH) | 2026-05-21 | — | — | US | claimed |
| US-20250017207-A1 | FUNGICIDAL COMPOSITIONS | SYNGENTA CROP PROTECTION AG (CH) | 2025-01-16 | — | — | US | claimed |
| EP-4422404-A1 | FUNGICIDAL COMPOSITIONS | Syngenta Crop Protection AG (CH) | 2024-09-04 | — | — | EP | claimed |
| EP-4422402-A1 | FUNGICIDAL COMPOSITIONS COMPRISING FLUDIOXONIL | Syngenta Crop Protection AG (CH) | 2024-09-04 | — | — | EP | claimed |
| WO-2023072785-A1 | FUNGICIDAL COMPOSITIONS | SYNGENTA CROP PROTECTION AG (CH) | 2023-05-04 | — | — | WO | claimed |
| WO-2023072784-A1 | FUNGICIDAL COMPOSITIONS COMPRISING FLUDIOXONIL | SYNGENTA CROP PROTECTION AG (CH) | 2023-05-04 | — | — | WO | claimed |
| WO-2020127319-A1 | PLANT GROWTH REGULATOR COMPOSITIONS | SYNGENTA CROP PROTECTION AG (CH) | 2020-06-25 | — | — | WO | claimed |
| US-20140309273-A1 | COMPOUNDS AND METHODS OF TREATING OBESITY | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2014-10-16 | — | — | US | claimed |
| EP-2347655-A1 | SYNERGISTIC FUNGICIDAL COMPOSITIONS | Syngenta Participations AG. (CH) | 2011-07-27 | — | — | EP | claimed |
| EP-2332411-A1 | Fungicidal compositions | Syngenta Participations AG (CH) | 2011-06-15 | — | — | EP | claimed |
| US-20080070785-A1 | For controlling phytopathogenic diseases; synergistic | SYNGENTA CROP PROTECTION, INC. (US) | 2008-03-20 | — | — | US | claimed |
| US-20070244121-A1 | Synergistic Fungicidal Compositions | SYNGENTA CROP PROTECTION, INC. (US) | 2007-10-18 | — | — | US | claimed |
| EP-1802198-A1 | SYNERGISTIC FUNGICIDAL COMPOSITIONS | Syngeta Participations AG (CH) | 2007-07-04 | — | — | EP | claimed |
| EP-1796464-A1 | FUNGICIDAL COMPOSITIONS | Syngeta Participations AG (CH) | 2007-06-20 | — | — | EP | claimed |
| EP-1778013-A1 | FUNGICIDAL COMPOSITIONS | Syngeta Participations AG (CH) | 2007-05-02 | — | — | EP | claimed |
| WO-2007009661-A2 | PESTICIDAL MIXTURES CONTAINING BICYCLIC ANTHRANILAMIDES | SYNGENTA PARTICIPATIONS AG (CH) | 2007-01-25 | — | — | WO | claimed |
| WO-2006037632-A1 | SYNERGISTIC FUNGICIDAL COMPOSITIONS | SYNGENTA PARTICIPATIONS AG (CH) | 2006-04-13 | — | — | WO | claimed |
| WO-2006037633-A1 | FUNGICIDAL COMPOSITIONS | SYNGENTA PARTICIPATIONS AG (CH) | 2006-04-13 | — | — | WO | claimed |
| WO-2006037634-A1 | FUNGICIDAL COMPOSITIONS | SYNGENTA PARTICIPATIONS AG (CH) | 2006-04-13 | — | — | WO | claimed |
| WO-2006015865-A1 | FUNGICIDAL COMPOSITIONS | SYNGENTA PARTICIPATIONS AG (CH) | 2006-02-16 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250017207-A1 | FUNGICIDAL COMPOSITIONS | CYP51A1, BROX, DPM1 | FAAH 3241/4885TRPV1 4588/4885TSHR 4533/4885 |
| US-20140309273-A1 | COMPOUNDS AND METHODS OF TREATING OBESITY | FABP4, LIPC, GPR119 | FAAH 116/4885TRPV1 2146/4885TSHR 3474/4885 |
| US-20260137082-A1 | FUNGICIDAL COMPOSITIONS COMPRISING FLUDIOXONIL | NOTUM, CTRL, BROX | FAAH 1004/4885TRPV1 4186/4885TSHR 3379/4885 |
| US-20070244121-A1 | Synergistic Fungicidal Compositions | DDT, CRY1, HCN1 | FAAH 2054/4885TRPV1 1081/4885TSHR 3282/4885 |
| US-20080070785-A1 | For controlling phytopathogenic diseases; synergistic | BROX, EPM2A, MANBA | FAAH 3187/4885TRPV1 3772/4885TSHR 4710/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.